Niagen Bioscience, Inc. (NAGE) stock
NAGENasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3011% below fair value
$2.04+0.03 (+1.49%)
Close on Nov 17, 2026Market cap $161.42MP/E 17.0Yield –
Niagen Bioscience total assets
Total assets on the balance sheet at the end of each period.
Niagen Bioscience's total assets was $108.69M at Sep 30, 2026. For fiscal 2025 it was $106.41M, up 55.8% from the year before. Over ten years it grew 19.0% a year on average. The highest annual figure on record is $106.41M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $106.41M | +55.8% |
| FY2024 | Dec 31, 2024 | $68.28M | +24.2% |
| FY2023 | Dec 31, 2023 | $54.96M | +1.7% |
| FY2022 | Dec 31, 2022 | $54.06M | -6.5% |
| FY2021 | Dec 31, 2021 | $57.84M | +50.8% |
| FY2020 | Dec 31, 2020 | $38.36M | -4.7% |
| FY2019 | Dec 31, 2019 | $40.25M | -4.7% |
| FY2018 | Dec 31, 2018 | $42.23M | -32.7% |
| FY2017 | Dec 30, 2017 | $62.72M | +217.6% |
| FY2016 | Dec 31, 2016 | $19.75M | +5.3% |
| FY2015 | Jan 2, 2016 | $18.75M | +62.8% |
| FY2014 | Jan 3, 2015 | $11.52M | +28.2% |
| FY2013 | Dec 28, 2013 | $8.99M | -0.5% |
| FY2012 | Dec 29, 2012 | $9.03M | +44.1% |
| FY2011 | Dec 31, 2011 | $6.27M | -3.6% |
| FY2010 | Jan 1, 2011 | $6.51M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $108.69M | +10.8% |
| Q2 FY2026 | Jun 30, 2026 | $106.59M | +16.5% |
| Q1 FY2026 | Mar 31, 2026 | $114.33M | +40.6% |
| Q4 FY2025 | Dec 31, 2025 | $106.41M | +55.8% |
| Q3 FY2025 | Sep 30, 2025 | $98.14M | +73.6% |
| Q2 FY2025 | Jun 30, 2025 | $91.53M | +69.4% |
| Q1 FY2025 | Mar 31, 2025 | $81.34M | +50.4% |
| Q4 FY2024 | Dec 31, 2024 | $68.28M | +24.2% |
| Q3 FY2024 | Sep 30, 2024 | $56.52M | +5.7% |
| Q2 FY2024 | Jun 30, 2024 | $54.04M | +1.6% |
| Q1 FY2024 | Mar 31, 2024 | $54.08M | +0.6% |
| Q4 FY2023 | Dec 31, 2023 | $54.96M | +1.7% |
| Q3 FY2023 | Sep 30, 2023 | $53.48M | +17.1% |
| Q2 FY2023 | Jun 30, 2023 | $53.17M | +14.1% |
| Q1 FY2023 | Mar 31, 2023 | $53.77M | +1.6% |
| Q4 FY2022 | Dec 31, 2022 | $54.06M | -6.5% |
| Q3 FY2022 | Sep 30, 2022 | $45.67M | -24.5% |
| Q2 FY2022 | Jun 30, 2022 | $46.61M | -29.2% |
| Q1 FY2022 | Mar 31, 2022 | $52.93M | -23.3% |
| Q4 FY2021 | Dec 31, 2021 | $57.84M | +50.8% |
| Q3 FY2021 | Sep 30, 2021 | $60.45M | +61.6% |
| Q2 FY2021 | Jun 30, 2021 | $65.84M | +56.8% |
| Q1 FY2021 | Mar 31, 2021 | $68.99M | +93.7% |
| Q4 FY2020 | Dec 31, 2020 | $38.36M | -4.7% |
| Q3 FY2020 | Sep 30, 2020 | $37.42M | -13.3% |
| Q2 FY2020 | Jun 30, 2020 | $41.99M | -5.7% |
| Q1 FY2020 | Mar 31, 2020 | $35.61M | -15.1% |
| Q4 FY2019 | Dec 31, 2019 | $40.25M | -4.7% |
| Q3 FY2019 | Sep 30, 2019 | $43.14M | -8.3% |
| Q2 FY2019 | Jun 30, 2019 | $44.54M | -14.6% |
| Q1 FY2019 | Mar 31, 2019 | $41.93M | -27.0% |
| Q4 FY2018 | Dec 31, 2018 | $42.23M | -32.7% |
| Q3 FY2018 | Sep 30, 2018 | $47.02M | +12.5% |
| Q2 FY2018 | Jun 30, 2018 | $52.17M | +58.5% |
| Q1 FY2018 | Mar 31, 2018 | $57.45M | +190.8% |
| Q4 FY2017 | Dec 30, 2017 | $62.72M | +234.3% |
| Q3 FY2017 | Sep 30, 2017 | $41.80M | – |
| Q2 FY2017 | Jul 1, 2017 | $32.92M | – |
| Q4 FY2016 | Dec 31, 2016 | $19.75M | – |
| Q3 FY2016 | Oct 1, 2016 | $18.76M | – |
See a number that looks wrong?